News Focus
News Focus
icon url

caravon

03/07/13 10:06 AM

#157923 RE: DewDiligence #157917

In my book, Perlmutter is not a big asset. At Amgen, he moved into Ph3 trials without appropriately doing Ph2 resulting in big failures. But he definitely has a big mouth.